1. Home
  2. GIPR vs INBS Comparison

GIPR vs INBS Comparison

Compare GIPR & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Generation Income Properties Inc.

GIPR

Generation Income Properties Inc.

HOLD

Current Price

$0.59

Market Cap

6.4M

Sector

Real Estate

ML Signal

HOLD

INBS

Intelligent Bio Solutions Inc.

HOLD

Current Price

$5.02

Market Cap

6.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GIPR
INBS
Founded
2015
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4M
6.4M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
GIPR
INBS
Price
$0.59
$5.02
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
50.5K
128.0K
Earning Date
03-31-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,953,920.00
$3,581,322.00
Revenue This Year
$1.12
$778.48
Revenue Next Year
$0.52
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
18.14
52 Week Low
$0.54
$4.03
52 Week High
$2.06
$27.50

Technical Indicators

Market Signals
Indicator
GIPR
INBS
Relative Strength Index (RSI) 39.76 34.64
Support Level $0.54 $8.03
Resistance Level $0.70 $7.40
Average True Range (ATR) 0.05 0.72
MACD -0.01 -0.58
Stochastic Oscillator 22.17 6.62

Price Performance

Historical Comparison
GIPR
INBS

About GIPR Generation Income Properties Inc.

Generation Income Properties Inc is an internally managed real estate investment company focused on acquiring and managing income-producing retail, office and industrial properties net leased to high-quality tenants in markets throughout the United States. Its key source of revenue is the rental income. The company holds properties in Alabama, Arizona, Colorado, the District of Columbia, Florida, Illinois, North Carolina and Virginia.

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.

Share on Social Networks: